ImmunityBio, Inc. (IBRX)
NASDAQ · Healthcare
ImmunityBio, Inc. Gross Margin 2013–2025
Current and historical gross margin for ImmunityBio, Inc. (IBRX) over the last 10 years. The current gross profit margin for ImmunityBio, Inc. as of December 31, 2025 is 99.34%.
From: 12/31/2013To: 12/31/2025
Revenue
Gross Profit
Gross Margin
ImmunityBio, Inc. Gross Margin — FAQ
ImmunityBio, Inc. (IBRX) gross margin over the last 13 years — annual and quarterly figures with year-over-year growth and charts.
What is ImmunityBio, Inc.'s gross margin?
ImmunityBio, Inc. (IBRX) reported gross margin of 99.3% for fiscal 2025.
Where can I see IBRX's gross margin history?
The chart and table above show ImmunityBio, Inc.'s gross margin by year and by quarter, including the growth rate.